张宇清:清晨家庭血压测量对心血管事件监测十分重要,从HONEST研究说起

2015-09-20 门诊 门诊

研究背景HONEST研究是日本一项前瞻性、观察性研究,纳入21591例2009年-2010年采用以奥美沙坦(10或20mg/d)为基础的治疗方案、原发性高血压门诊患者,主要终点为主要心血管事件,包括脑梗死、颅内出血、蛛网膜下腔出血、未知类型卒中、心肌梗死、因心绞痛行冠状动脉血运重建或猝死。该研究随访2年,随访期间于多个时段检测家庭血压和诊室血压,评估与诊室血压相比,清晨家测血压与心血管事件发生率之

研究背景

HONEST研究是日本一项前瞻性、观察性研究,纳入21591例2009年-2010年采用以奥美沙坦(10或20mg/d)为基础的治疗方案、原发性高血压门诊患者,主要终点为主要心血管事件,包括脑梗死、颅内出血、蛛网膜下腔出血、未知类型卒中心肌梗死、因心绞痛行冠状动脉血运重建或猝死。该研究随访2年,随访期间于多个时段检测家庭血压和诊室血压,评估与诊室血压相比,清晨家测血压与心血管事件发生率之间的关系。

HONEST研究:探讨家庭血压对心血管预后的影响
  
首先,从高血压管理层面来看,目前对家庭血压测量的需要越来越大,它可以加强医生和患者之间的互动,有助于改善患者的依从性,使其更好地坚持治疗;另外,目前缺乏家庭血压对预后影响的评估。HONEST研究的价值就在于将家庭血压测量这一指标引入进来,探讨其对心血管预后的影响。

HONEST研究主要结果和意义

奥美沙坦平稳持久降压:血压方面,该研究随访两年显示,以奥美沙坦为基础的降压方案治疗2年,可平稳持久降低清晨家测血压和诊室血压。

清晨家测血压与心血管风险相关:当清晨家测SBP≥145 mmHg或诊室SBP≥150 mmHg时,患者的心血管风险较高;而即使在诊室血压已经降至正常或良好(<130 mm Hg)的情况下,如果清晨家测血压仍然比较高(SBP≥145 mmHg),则患者的心血管风险依然较高;当清晨或夜间家测SBP为124 mmHg时,患者的心血管风险最小。

HONEST研究虽然并非随机对照试验,本身有一定局限性,但其优势和价值在于它是一项纳入21591例高血压患者的大规模研究,是来自真实世界的数据,与临床实践相对更为符合;它进行了一种新的尝试,在研究中引入了家庭血压这一监测指标,并与诊室血压进行了比较。这有助于引起大家对这一指标的重视,医生在临床诊疗实践中可能也会更多地考虑家庭血压的变化情况,考查其与诊室血压是否一致,若二者一致达标则可以预判患者预后会比较好,而若诊室血压正常但家庭血压偏高,则要考虑是否合并存在隐蔽性高血压或其他问题,从而进行干预和解决,这将有助于加强患者整体的血压管理质量。

HONEST研究启示家庭血压监测的重要性

该结果带给我们的重要启示是,单纯用诊室血压评估疗效在一定程度上可能会低估治疗不足的危害;在已经接受治疗的高血压患者中,只采用诊室血压评估,可能还会存在部分隐蔽性高血压的问题;只有在两种检测手段即诊室血压和家测血压都达标的情况下,患者的事件发生率才是最低的。下一步我们也许需要探讨到底是什么原因导致家庭血压控制不良,是否有焦虑的因素,是否与合并其他危险因素有关,这可能也是后续研究中需要考虑的一个问题。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
    2015-09-21 lovejing

    内容好,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2050493, encodeId=657b2050493bc, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Dec 10 07:28:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973981, encodeId=37f019e398125, content=<a href='/topic/show?id=d7c149942b8' target=_blank style='color:#2F92EE;'>#张宇清#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49942, encryptionId=d7c149942b8, topicName=张宇清)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/JHX80Wpw3cstP6RtQ1pO8asyNiah0uIJwh7hmKm1emARpicBibTeQrj1SN7YwGSwibOrIL2kZ9WHmRiaznSnuHhUJUg/132, createdBy=c7de2500155, createdName=ms3415360956839622, createdTime=Sat Feb 20 09:28:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643372, encodeId=d29316433e211, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Oct 05 09:28:00 CST 2015, time=2015-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679360, encodeId=91ca16e936067, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Mar 24 10:28:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37085, encodeId=b6373e085f2, content=内容好,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e0b1603164, createdName=lovejing, createdTime=Mon Sep 21 07:22:00 CST 2015, time=2015-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37059, encodeId=92053e05932, content=学习了,晨峰血压, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Sep 21 06:59:00 CST 2015, time=2015-09-21, status=1, ipAttribution=)]
    2015-09-21 nizongzan

    学习了,晨峰血压

    0

相关资讯

张宇清:ESH-ISH高血压会议2014亮点集锦

一、高血压全基因组关联研究取得进展 目前在高血压的遗传学研究中一直缺乏突破性的进展,现任ESH主席、英国格拉斯哥大学的Anna F. Dominiczak教授在主席演讲报告中提出的根据全基因组关联研究(GWAS)显示,尿调蛋白基因与血压水平相关。她在演讲中强调,GWAS研究的主要目的是寻找与疾病的关联基因,而这只是开始,随后还需对关联基因进行功能性研究。目前有些检测到的单核苷

张宇清教授:SPRINT试验提示相对健康患者群,强化降压更获益

今天整个互联网都吵得很热:一项提前终止的大型临床试验警世 : 高血压治疗指标下调刻不容缓(SPRINT 研究)(这是科学网水迎波的博客)。看看中国医学科学院阜外医院张宇清教授对此的评价。

张宇清:从2013 ESH指南看SPC在降压治疗中的地位

欧洲高血压学会/欧洲心脏病学会(ESH/ESC)高血压治疗指南一直是世界上被引用最多的医学文献之一,第一版指南问世于10年前。这10年是高血压防治研究快速发展的10年,在许多方面都取得了新的进展。2013年,ESH/ESC工作组回顾了自上次修订版(2007年)以来的所有相关数据,对高血压的治疗做出了科学推荐,发布了ESH/ESC 2013动脉高血压管理指南 。中国医学科学院阜外心血管病医院的张宇清